Journal of Bone Oncology

Papers
(The median citation count of Journal of Bone Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
#15. Single-cell discovery and multi-omic characterization of therapeutic targets in multiple myeloma94
From bimodal to unimodal: The transformed incidence of osteosarcoma in the United States50
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approaches45
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma43
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw39
MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p36
Senescence in the bone marrow microenvironment: A driver in development of therapy-related myeloid neoplasms34
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets27
Macrophage heterogeneity in bone metastasis25
State-of-the-art of minimally invasive treatments of bone metastases21
Frequency and reason for reoperation following non-invasive expandable endoprostheses: A systematic review20
Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study20
#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma20
Adoption of adjuvant bisphosphonates for early breast cancer into standard clinical practice: Challenges and lessons learnt from comparison of the UK and Australian experience20
#41. Discovery of novel tubulin code in bone metastasis of breast cancer20
A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors18
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response18
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer18
Preoperative prediction of high-grade osteosarcoma response to neoadjuvant therapy based on a plain CT radiomics model: A dual-center study17
Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer17
#49. Complete estrogen-deprived athymic nude mice are susceptible to changes in metabolism and musculoskeletal function mediated by a high-fat diet15
#6. Mechanical loading of breast cancer laden bones alters osteocyte mediated bone loss in vivo15
#2. Homing of intestinal NK and Th1 cells to the tumor site restrains melanoma bone growth in a gut microbiome dependent manner14
#31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER14
#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone14
Periacetabular reconstruction following limb-salvage surgery for pelvic sarcomas13
Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices13
Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review13
The perplexing role of immuno-oncology drugs in osteosarcoma13
Intraosseous conventional central chondrosarcoma does not metastasise irrespective of grade in pelvis, scapula and in long bone locations13
Molecular imaging of bone metastasis12
Targeting stromal p38MAPKalpha triggers innate-adaptive anti-tumor immunity and sensitizes metastatic breast cancer to immunotherapy12
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases12
LncRNA SATB2-AS1 promotes tumor growth and metastasis and affects the tumor immune microenvironment in osteosarcoma by regulating SATB212
FemurTumorNet: Bone tumor classification in the proximal femur using DenseNet model based on radiographs12
#14. Determining how prostate cancer cell heterogeneity promotes bone metastasis using fluid-walled microfluidics12
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms11
Incidence and radiotherapy treatment patterns of complicated bone metastases11
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties11
Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma11
Impact of myosteatosis on prognosis in multiple myeloma patients: A subgroup analysis of 182 cases and development of a nomogram11
Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents10
#50. Investigating the role of EphA2 in breast cancer bone metastasis10
#51. High dimensional profiling of human prostate metastatic bone marrow microenvironment using mass cytometry10
The roles of the FL/FLT3 axis in the development of cancer-induced bone pain mediated by prostate cancer10
#8. Radium-223 treated primary patient bone biopsy analysis: Macro to microscale analyses and dosimetry10
Mixed reality infrastructure based on deep learning medical image segmentation and 3D visualization for bone tumors using DCU-Net9
#7. Downstream effects of Gli2 targeting on tumor-immune cell crosstalk in bone metastatic breast cancer9
Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone9
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target9
Giant cell tumor of bone: A single center study of 115 cases9
Automatic classification of spinal osteosarcoma and giant cell tumor of bone using optimized DenseNet9
Bones and guts – Why the microbiome matters9
Latest developments in the pathobiology of Ewing sarcoma9
#45. Fatty acid binding proteins may modulate myeloma in Fabp4/5 double knockout mouse9
YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD5229
Does liquid nitrogen recycled autograft for treatment of bone sarcoma impact local recurrence rate? A systematic review9
Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis8
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical pr8
Non-POEMS osteosclerotic multiple myeloma: Clinical characteristics and differential diagnosis8
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathway8
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature8
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner8
A novel adjunctive diagnostic method for bone cancer: Osteosarcoma cell segmentation based on Twin Swin Transformer with multi-scale feature fusion8
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-3848
Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin7
Surgical Options for Aggressive Vertebral Hemangiomas:A case series, literature review and treatment recommendations7
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones7
The role of IL-1B in breast cancer bone metastasis7
Determinants of tumor necrosis and its impact on outcome in patients with Localized osteosarcoma uniformly treated with a response adapted regimen without high dose Methotrexate– A retrospective insti7
Groenlandicine enhances cisplatin sensitivity in cisplatin-resistant osteosarcoma cells through the BAX/Bcl-2/Caspase-9/Caspase-3 pathway7
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study7
Let-7a suppresses Ewing sarcoma CSCs’ malignant phenotype via forming a positive feedback circuit with STAT3 and lin287
The 100 most cited papers on bone metastasis: A bibliometric analysis7
Deep hashing and attention mechanism-based image retrieval of osteosarcoma scans for diagnosis of bone cancer7
Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord7
Auxiliary diagnosis of primary bone tumors based on Machine learning model7
Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas6
Diagnosis of newly developed multiple myeloma without bone disease detectable on conventional computed tomography (CT) scan by using dual-energy CT6
Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa6
Analysis of morbidity and mortality in patients with primary bone tumors who underwent sacrectomy: A systematic review6
Pharmacologic Hedgehog inhibition modulates the cytokine profile of osteolytic breast cancer cells6
Radiographic imaging and diagnosis of spinal bone tumors: AlexNet and ResNet for the classification of tumor malignancy6
Essential genes analysis reveals small ribosomal subunit protein eS28 may be a prognostic factor and potential vulnerability in osteosarcoma6
#13. 3D printed bioactive glasses porous scaffolds with high strength for the repair of long-bone segmental defects6
BMS-794833 reduces anlotinib resistance in osteosarcoma by targeting the VEGFR/Ras/CDK2 pathway6
An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging6
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma6
AI diagnostics in bone oncology for predicting bone metastasis in lung cancer patients using DenseNet-264 deep learning model and radiomics6
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial6
Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer6
Predicting bone metastasis risk of colorectal tumors using radiomics and deep learning ViT model5
EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways5
CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p5
Automated measurement of lumbar pedicle screw parameters using deep learning algorithm on preoperative CT scans5
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors5
Quality of resection margin with patient specific instrument for bone tumor resection5
Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis5
CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy5
#12. Potential role of bone metastasis-associated fibroblasts in prostate cancer-induced bone pain5
Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma5
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis5
#43. Long-chain acyl-CoA synthetases support multiple myeloma cell proliferation, survival and mitochondrial function5
Erratum to “Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma” [J. Bone Oncol. 26 (2021) 100331]4
Prognostic factors and survival of patients undergoing surgical intervention for breast cancer bone metastases4
Is surgery without curettage effective for periacetabular Metastasis? Insights from a survival study of 93 patients4
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval4
#5. Activating RET mutations in medullary thyroid cancer cells promotes osteoblastic bone metastasis by inhibiting osteoclastogenesis and stimulating osteoblast activity4
Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: A report of 11 cases in a single center4
#21. PD-1 blockade induces bone loss and reduces bone strength in a breast cancer bone metastasis model4
Emerging roles for stromal cells in bone metastasis4
#35. Defining short-form RON mediated anti-tumor immunity in breast cancer bone metastasis4
Bone-derived excess TGF-ß release is associated with cognitive dysfunction due to oxidation of RyR, Ca2+ leak and mitochondrial dysfunction4
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors4
Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis4
Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cells4
Bone tumor examination based on FCNN-4s and CRF fine segmentation fusion algorithm4
Study of imaging changes following preoperative denosumab for giant cell tumor of bone4
#3. IL-17A supports osteoblasts to become cancer-associated fibroblasts in breast cancer bone metastases4
#38. Cholesterol increases bone marrow tumour burden in myeloma in vivo and promotes myeloma cell viability and bortezomib resistance ex vivo3
Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing’s sarcoma survivors: A scoping review3
Establishment and characterization of a highly metastatic human osteosarcoma cell line from osteosarcoma lung metastases3
Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review3
#39. Bone-derived Dickkopf-related protein 1 supports primary breast cancer growth and alters hematopoiesis3
Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy3
In vitro three-dimensional cell cultures for bone sarcomas3
The patterns of distant metastasis and prognostic factors in patients with primary metastatic Ewing sarcoma of the bone3
Adipocytes and metabolism: Contributions to multiple myeloma3
Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix3
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review3
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment2
Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data2
RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines2
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer2
Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases2
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients2
#30. Fractures in metastatic hormone-sensitive prostate cancer (mHSPC). Results from two phase 3 trials from the STAMPEDE platform2
The validity of the distress thermometer in patients with musculoskeletal tumors2
Epigenetic control of the vicious cycle2
#24. Mechanical loading-induced changes to the bone microenvironment control bone metastatic breast cancer lesions2
Bone density measurement in patients with spinal metastatic tumors using chest quantitative CT deep learning model2
The METTL3/TGF-β1 signaling axis promotes osteosarcoma progression by inducing MSC differentiation into CAFs via m6A modification2
Senolytics deplete senescent osteocytes and improve bone health in metastatic breast cancer2
Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients2
#47. Chemotherapy-induced microenvironmental changes promote dormant breast cancer cell growth in the adipose tissue2
Surgical margin assessment of bone tumours: A systematic review of current and emerging technologies2
#29. A novel control mechanism of endosomal trafficking in bone metastatic breast cancer cells2
Imaging evaluation of blood supply changes after chemotherapy of osteosarcoma and its correlation with tumor necrosis rate2
Comprehensive diagnostic model for osteosarcoma classification using CT imaging features2
MUTARS® Humero pro Femur replacement: A novel reconstructive procedure after malignant bone tumor resection of the femur in young children2
-AI-assisted diagnostic potential of CT in bone oncology and its impact on clinical decision-making for intensive care2
#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis2
Preoperative CT for prediction of local recurrence after curettage of giant cell tumor of bone2
Pelvic bone tumor segmentation fusion algorithm based on fully convolutional neural network and conditional random field2
Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors2
Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK12
Efficacy of replacing actinomycin-D with carboplatin in Ewing sarcoma consolidation treatment: Single-center experience2
0.0728440284729